Top Markets
#1 Helium Helium +41.95%
#2 Seeker Seeker +35.56%
#3 TENDIES TENDIES +31.40%
#4 Pons Pons +29.86%
#5 UnifAI Network UnifAI Network +19.14%
#6 Zylo Ecosystem Zylo Ecosystem +16.99%
#7 DAPPOS DAPPOS +16.76%
#8 ZKsync ZKsync +15.63%
#9 Zora Zora +14.87%
#10 pipedog pipedog +14.42%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Rank in Stocks #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Share Price
$5.52
Last synced: 2025-10-09
Market Cap
$775.10M
Change (1 day)
1.28%
Change (1 year)
15.48%
Country
US
Trade BioSig Technologies, Inc. (BSGM)

Category

Healthcare
Revenue for BioSig Technologies, Inc. (BSGM)
Revenue in Sep 2025 TTM: $13.00K
According to BioSig Technologies, Inc. latest financial reports the company's current revenue (TTM) is $13.00K. In 2023 the company made a revenue of $18.00K a decrease compared to the revenue in the year 2022 that was $286.00K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioSig Technologies, Inc. from 2011 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $13.00K -67.50%
2024 $40.00K 122.22%
2023 $18.00K -93.71%
2022 $286.00K -35.15%
2021 $441.00K 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 358,346,053.85%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 198,746,053.85%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 272,953,746.15%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 161,507,592.31%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE